» Articles » PMID: 10711963

Biomaterials Used in the Posterior Segment of the Eye

Overview
Journal Biomaterials
Date 2000 Mar 11
PMID 10711963
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The treatment of posterior segment eye disease and related conditions has improved greatly in recent years with the advent of new therapies, materials and devices. Vitreoretinal conditions, however, remain significant causes of blindness in the developed world. Biomaterials play a major role in the treatment of many of these disorders and the success rate of vitreoretinal surgery, especially in the repair of retinal detachment and related conditions, would increase with the introduction of new and improved materials. This review, which focuses on disorders that feature retinal detachment, briefly describes the anatomy of the eye and the nature and treatment of posterior segment eye disorders. The roles, required properties and suitability of the materials used in vitreoretinal surgery as scleral buckles, tamponade agents or drug delivery devices, are reviewed. Experimental approaches are discussed, along with the methods used for their evaluation, and future directions for biomaterial research in the posterior segment of the eye are considered.

Citing Articles

Large-scale synthesis of polydimethylsiloxane as vitreous replacement applications.

Shabrina A, Auliya D, Risdiana , Safriani L Des Monomers Polym. 2025; 28(1):1-6.

PMID: 39802405 PMC: 11721900. DOI: 10.1080/15685551.2024.2449442.


Innovative Strategies for Drug Delivery to the Ocular Posterior Segment.

Gabai A, Zeppieri M, Finocchio L, Salati C Pharmaceutics. 2023; 15(7).

PMID: 37514050 PMC: 10385847. DOI: 10.3390/pharmaceutics15071862.


Vitreous Substitutes from Bench to the Operating Room in a Translational Approach: Review and Future Endeavors in Vitreoretinal Surgery.

Confalonieri F, Josifovska N, Boix-Lemonche G, Stene-Johansen I, Bragadottir R, Lumi X Int J Mol Sci. 2023; 24(4).

PMID: 36834754 PMC: 9961686. DOI: 10.3390/ijms24043342.


Vitreous Substitutes as Drug Release Systems.

Schulz A, Szurman P Transl Vis Sci Technol. 2022; 11(9):14.

PMID: 36125790 PMC: 9508686. DOI: 10.1167/tvst.11.9.14.


Nanomedicine and drug delivery to the retina: current status and implications for gene therapy.

Tawfik M, Chen F, Goldberg J, Sabel B Naunyn Schmiedebergs Arch Pharmacol. 2022; 395(12):1477-1507.

PMID: 36107200 PMC: 9630211. DOI: 10.1007/s00210-022-02287-3.